BeOne Medicines
ONC
#856
Rank
S$37.15 B
Marketcap
S$358.10
Share price
1.57%
Change (1 day)
10.36%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2026 (TTM): S$6.17

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is S$6.17. In 2025 the company made an earnings per share (EPS) of S$3.50 an increase over its 2024 EPS that were of S-$8.01.

EPS history for BeOne Medicines from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$6.1776.14%
2025S$3.50-143.75%
2024S-$8.01
2022S-$25.0328.21%
2021S-$19.52-19.96%
2020S-$24.3920.81%
2019S-$20.1931.52%
2018S-$15.35417.57%
2017S-$2.97-37.16%
2016S-$4.72158.95%
2015S-$1.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
S-$0.31-104.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
S-$1.22-119.75%๐Ÿ‡บ๐Ÿ‡ธ USA